Nusinersen and risdiplam for treating spinal muscular atrophy (review of TA588 and TA755) [ID6195]
In development
Reference number: GID-TA11386
Expected publication date: TBC
Further to the last update of 12 March 2026, we can now confirm that we anticipate sending the final draft guidance confidentially to stakeholders in the week commencing 4 May 2026 and publishing it on the NICE website 1 week later.